Clinical Trial Update: The Identification of Novel Prognostic Markers in Melanoma

View source ↗

Summary

This document reports a clinical trial update focused on identifying novel prognostic markers in melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Malignant Melanoma | Status: UNKNOWN